COPD Archives - Journal for Clinical Studies

Volume 13 Issue 4

Respiratory Disease Diagnosis and Testing Beyond COVID-19

Over the last year, the COVID-19 pandemic has placed healthcare for respiratory medicine firmly in the global spotlight. But even before this, over half a billion peo...

9 August 2021 Volume 13 Issue 4 asthma | chronic obstructive pulmonary disease

Continue Reading →

Europe

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the second of two Phase...

6 June 2018 Europe 2nd | AstraZeneca

Continue Reading →

news

Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced that GSK, a world leader in respiratory, will incorporate Owlstone ...

29 November 2017 news biopsy | breathalyzer

Continue Reading →

news

GSK study shows COPD ‘superiority’ for Anoro Ellipta versus Stiolto Respimat

GlaxoSmithKline’s (GSK) study showed that Anoro Ellipta is more effective than Stiolto Respimat in improving lung function in patients with chronic obstructive pulmon...

8 November 2017 news COPD | GSK

Continue Reading →

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

Respiratory Disease Diagnosis and Testing Beyond COVID-19

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial

GSK study shows COPD ‘superiority’ for Anoro Ellipta versus Stiolto Respimat

Journal for Clinical Studies